BioRoot™ Flow: a new root canal sealer in a syringe based on Active Biosilicate (ABS) Technology™

Septodont, a global leader in dental pharmaceuticals and medical devices, is proud to announce the launch of BioRoot™ Flow, the latest innovation in endodontic treatment. BioRoot™ Flow represents a significant advancement in dental care, building on the success of BioRoot™ RCS.

BioRoot™ Flow is a bioactive(1) root canal sealer

Designed to meet the highest standards of patient care and professional practice. Leveraging Septodont’s extensive history of research and development, this next-generation sealer combines cutting-edge bioactive technology with ease of use. Its formulation ensures optimal flowability, making it the ideal choice for effectively sealing root canals while prioritizing patient safety.

Clinically proven performance with 91% success rate after 2 years(2)

In a clinical study on 160 patients, BioRoot™ Flow has demonstrated an impressive 91% success rate over two years, exceeding the success rates found in the literature(3,4). This success provides dental professionals with confidence in achieving long-term patient outcomes both in routine and complex root canal procedures.

At the heart of BioRoot™ Flow is the groundbreaking ABS Technology™, a proprietary formulation that offers unmatched sealing ability and biocompatibility. This innovative technology ensures optimal adhesion to dentin, promoting long-term success by decreasing the risk of bacterial growth. Additionally, ABS Technology™ supports the natural healing process by encouraging the formation of hydroxyapatite, which integrates seamlessly with the tooth structure.

With the launch of BioRoot™ Flow, Septodont reaffirms its commitment to advancing dental care through innovation, providing clinicians with the tools they need to deliver exceptional outcomes and enhance patient well-being.